• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外生命支持在心脏手术后心源性休克中的应用:261 例患者的情况、结果和危险因素分析。

Extracorporeal Life Support in Postcardiotomy Cardiogenic Shock: A View on Scenario, Outcome, and Risk Factors in 261 Patients.

机构信息

Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.

Department of Clinical Studies, University Medical Center Regensburg, Regensburg, Germany.

出版信息

Thorac Cardiovasc Surg. 2021 Apr;69(3):271-278. doi: 10.1055/s-0040-1714746. Epub 2020 Sep 4.

DOI:10.1055/s-0040-1714746
PMID:32886928
Abstract

BACKGROUND

Weaning failure from cardiopulmonary bypass, postoperative low cardiac output (LCO), and cardiopulmonary resuscitation (CPR) are common scenarios preceding extracorporeal life support (ECLS) implantation after cardiac surgery. The impact of these scenarios on short- and long-term outcome are not well described.

METHODS

Between March 2006 and December 2018, 261 patients received ECLS support after cardiac surgery. Data of patients with weaning failure (NW), postoperative LCO, and CPR leading to ECLS implantation were retrospectively analyzed regarding outcome. Risk factors for outcome after postcardiotomy ECLS were assessed by uni- or multivariate regression analysis.

RESULTS

Median duration of extracorporeal support was 5.5 ± 8.5 days. Overall mortality on ECLS was 39.1%. Scenario analysis revealed weaning failure from cardiopulmonary bypass in 40.6%, postoperative LCO in 24.5%, and postoperative CPR in 34.9% leading to initiation of ECLS. Most common cause of death was refractory LCO (25.3%). Overall follow-up survival was 23.7%. Survival after weaning and during follow-up in all subgroups was 9.2% (CPR), 5.0% (LCO), and 9.6% (NW), respectively. Uni- or multivariate regression analysis revealed age, aortic surgery, and vasopressor medication level on day 1 as risk for death on support, as well as postoperative renal failure, and body mass index (BMI) as risk factors for death during follow-up.

CONCLUSION

Mortality after postcardiotomy ECLS is high. Overall, outcome after CPR, NW, weaning failure and LCO is comparable. Postoperative resuscitation does not negatively affect outcome after postcardiotomy ECLS. Neurological status of ECLS survivors is good.

摘要

背景

心肺转流术后脱机失败、术后低心输出量(LCO)和心肺复苏(CPR)是心脏手术后体外生命支持(ECLS)植入前常见的情况。这些情况对短期和长期结果的影响尚未得到很好的描述。

方法

2006 年 3 月至 2018 年 12 月,261 例心脏手术后患者接受 ECLS 支持。回顾性分析心肺转流术后脱机失败(NW)、术后 LCO 和 CPR 导致 ECLS 植入的患者的结局数据。采用单变量或多变量回归分析评估体外循环后 ECLS 结局的危险因素。

结果

体外循环支持的中位时间为 5.5±8.5 天。ECLS 上的总体死亡率为 39.1%。情景分析显示,心肺转流术脱机失败占 40.6%,术后 LCO 占 24.5%,术后 CPR 占 34.9%,导致 ECLS 启动。最常见的死亡原因是难治性 LCO(25.3%)。总体随访生存率为 23.7%。所有亚组的脱机和随访期间的生存率分别为 9.2%(CPR)、5.0%(LCO)和 9.6%(NW)。单变量或多变量回归分析显示,年龄、主动脉手术和第 1 天的血管加压药物水平是支持死亡率的危险因素,术后肾功能衰竭和体重指数(BMI)是随访死亡率的危险因素。

结论

心脏手术后 ECLS 的死亡率很高。总体而言,CPR、NW、脱机失败和 LCO 的预后相当。心肺复苏后不会对心脏手术后 ECLS 的预后产生负面影响。ECLS 幸存者的神经状态良好。

相似文献

1
Extracorporeal Life Support in Postcardiotomy Cardiogenic Shock: A View on Scenario, Outcome, and Risk Factors in 261 Patients.体外生命支持在心脏手术后心源性休克中的应用:261 例患者的情况、结果和危险因素分析。
Thorac Cardiovasc Surg. 2021 Apr;69(3):271-278. doi: 10.1055/s-0040-1714746. Epub 2020 Sep 4.
2
Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.经皮体外生命支持治疗难治性心源性休克患者:多学科团队的初步结果
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):283-91. doi: 10.1093/icvts/ivt505. Epub 2013 Dec 13.
3
Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.体外膜肺氧合在心脏手术后休克中的应用:死亡率的危险因素。
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1894-1902.e3. doi: 10.1016/j.jtcvs.2018.05.061. Epub 2018 Jun 4.
4
Resuscitation of non-postcardiotomy cardiogenic shock or cardiac arrest with extracorporeal life support: the role of bridging to intervention.体外生命支持复苏非心脏手术后心源性休克或心搏骤停:桥接介入治疗的作用。
Resuscitation. 2012 Aug;83(8):976-81. doi: 10.1016/j.resuscitation.2012.01.010. Epub 2012 Jan 21.
5
Clinical outcomes of venoarterial extracorporeal life support in 462 patients: Single-center experience.462 例患者应用脉动脉体外生命支持的临床结果:单中心经验。
Artif Organs. 2020 Jun;44(6):620-627. doi: 10.1111/aor.13625. Epub 2020 Feb 5.
6
Outcomes after extracorporeal life support for postcardiotomy cardiogenic shock.心脏术后心源性休克体外生命支持后的结果
J Card Surg. 2019 Feb;34(2):74-81. doi: 10.1111/jocs.13985. Epub 2019 Jan 12.
7
Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.体外膜肺氧合用于心脏术后心源性休克
Ann Thorac Surg. 1996 Feb;61(2):684-91. doi: 10.1016/0003-4975(95)01042-4.
8
Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry.体外膜肺氧合治疗心脏手术后休克-体外生命支持组织登记分析。
Crit Care Med. 2021 Jul 1;49(7):1107-1117. doi: 10.1097/CCM.0000000000004922.
9
Extracorporeal life support in the multidisciplinary management of cardiogenic shock complicating acute myocardial infarction.体外生命支持在急性心肌梗死后合并心原性休克的多学科综合管理中的应用。
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):E71-E77. doi: 10.1002/ccd.28316. Epub 2019 Apr 29.
10
The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.体外膜肺氧合支持下心内直视术后患者乳酸的早期动态变化与死亡率相关:一项回顾性观察研究。
J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50. doi: 10.1016/j.jtcvs.2014.11.052. Epub 2014 Nov 24.

引用本文的文献

1
Mechanical Circulatory Support in Cardiovascular Surgical Patients: Single Center Practice and Experience.心血管外科患者的机械循环支持:单中心实践与经验
Rev Cardiovasc Med. 2022 Aug 24;23(9):291. doi: 10.31083/j.rcm2309291. eCollection 2022 Sep.
2
Mortality on extracorporeal membrane oxygenation: Evaluation of independent risk factors and causes of death during venoarterial and venovenous support.体外膜肺氧合患者的死亡率:静脉-动脉和静脉-静脉支持期间独立危险因素和死亡原因的评估。
Perfusion. 2024 Nov;39(8):1648-1656. doi: 10.1177/02676591231212997. Epub 2023 Nov 7.
3
Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock.
经心脏手术后心原性休克患者中 Impella 支持对临床结局的影响。
Ann Thorac Cardiovasc Surg. 2024 Jan 26;30(1). doi: 10.5761/atcs.oa.23-00076. Epub 2023 Aug 3.
4
Identification of diagnostic markers and immune cell infiltration characteristics in antineutrophil cytoplasmic antibody-associated vasculitis by weighted gene co-expression network analysis.基于加权基因共表达网络分析鉴定抗中性粒细胞胞质抗体相关性血管炎的诊断标志物及免疫细胞浸润特征。
Eur J Med Res. 2022 Mar 5;27(1):37. doi: 10.1186/s40001-022-00666-3.